Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Karin Jirström"'
Autor:
Nina Andersson, Johan Ohlsson, Sara Wahlin, Björn Nodin, Karolina Boman, Sebastian Lundgren, Karin Jirström
Publikováno v:
Biomarker Research, Vol 8, Iss 1, Pp 1-12 (2020)
Abstract Background Screening across a multitude of normal and malignant tissues revealed an enhanced expression of lymphocyte antigen 6 superfamily member D (LY6D) in squamous epithelium and urothelium, as well as in malignancies derived therefrom.
Externí odkaz:
https://doaj.org/article/8cd3615ce1694fa59e4244c2099b701c
Autor:
Gustav Andersson, Sebastian Lundgren, Margareta Heby, Björn Nodin, Jacob Elebro, Karin Jirström
Publikováno v:
Biomarker Research, Vol 7, Iss 1, Pp 1-14 (2019)
Abstract Background Tamoxifen treatment has previously been reported to confer life-prolonging effects in patients with advanced pancreatic cancer, and most evidently so in women. None of these trials did however include biomarkers, and the relevance
Externí odkaz:
https://doaj.org/article/3c28b24ef1a5403283a27ca2e8fd9c3c
Autor:
Sebastian Lundgren, Helena Fagerström-Vahman, Cheng Zhang, Liv Ben-Dror, Adil Mardinoglu, Mathias Uhlen, Björn Nodin, Karin Jirström
Publikováno v:
Biomarker Research, Vol 7, Iss 1, Pp 1-6 (2019)
Abstract There is a great unmet clinical need to identify patients with thin primary cutaneous melanomas (T1, Breslow thickness ≤ 1 mm) who have a high risk for tumour recurrence and death from melanoma. Kin of IRRE-like protein 1 (KIRREL/NEPH1) is
Externí odkaz:
https://doaj.org/article/3ab0bd54648f4917a1a5a7cae0b24865
Autor:
Sara Wahlin, Sebastian Lundgren, Karolina Boman, Johan Ohlsson, Björn Nodin, Nina Andersson, Karin Jirström
Publikováno v:
Biomarker Research, Vol 8, Iss 1, Pp 1-12 (2020)
Biomarker Research
Biomarker Research
Background Screening across a multitude of normal and malignant tissues revealed an enhanced expression of lymphocyte antigen 6 superfamily member D (LY6D) in squamous epithelium and urothelium, as well as in malignancies derived therefrom. The aim o
Autor:
Margareta Heby, Gustav Andersson, Karin Jirström, Björn Nodin, Jacob Elebro, Sebastian Lundgren
Publikováno v:
Biomarker Research
Biomarker Research, Vol 7, Iss 1, Pp 1-14 (2019)
Biomarker Research, Vol 7, Iss 1, Pp 1-14 (2019)
Background Tamoxifen treatment has previously been reported to confer life-prolonging effects in patients with advanced pancreatic cancer, and most evidently so in women. None of these trials did however include biomarkers, and the relevance of femal
Autor:
Cheng Zhang, Karin Jirström, Sebastian Lundgren, Björn Nodin, Mathias Uhlén, Adil Mardinoglu, Liv Ben-Dror, Helena Fagerström-Vahman
Publikováno v:
Lundgren, S, Fagerstrom-Vahman, H, Zhang, C, Ben-Dror, L, Mardinoglu, A, Uhlen, M, Nodin, B & Jirstrom, K 2019, ' Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma ', BIOMARKER RESEARCH, vol. 7, no. 1, 1 . https://doi.org/10.1186/s40364-018-0153-8
Biomarker Research, Vol 7, Iss 1, Pp 1-6 (2019)
Biomarker Research
Biomarker Research, Vol 7, Iss 1, Pp 1-6 (2019)
Biomarker Research
There is a great unmet clinical need to identify patients with thin primary cutaneous melanomas (T1, Breslow thickness ≤ 1 mm) who have a high risk for tumour recurrence and death from melanoma. Kin of IRRE-like protein 1 (KIRREL/NEPH1) is expresse
Autor:
Richard Fristedt, David Borg, Anders Johnsson, Alexander Gaber, Jakob Eberhard, Charlotta Hedner, Björn Nodin, Karin Jirström
Publikováno v:
Biomarker Research
Background There is an increasing amount of reports on IFITM1 (interferon-inducible transmembrane protein 1) in various malignancies. The aim of this study was to examine the expression of IFITM1 and its prognostic significance in gastroesophageal ad
Autor:
Gustav Andersson, Karolina Boman, Björn Nodin, Karin Jirström, Christoffer Wennersten, Göran Ahlgren
Publikováno v:
Biomarker Research
Background Urothelial bladder cancer (UBC) is a disease that often is discovered when the tumour is non-muscle invasive, i.e. in Ta or T1 stage. Some patients will progress into muscle-invasive disease, a potentially deadly condition. Although there
Autor:
Alexander Gaber, Karin Jirström, Dejan Korkocic, Björn Nodin, Mathias Uhlén, Liv Jonsson, Charlotta Hedner, Jakob Eberhard
Publikováno v:
Biomarker research; 2(Jun 17), no 11 (2014)
Biomarker Research
Biomarker Research
Background High nuclear expression of the RNA-binding motif protein 3 (RBM3) has previously been found to correlate with favourable clinicopathological characteristics and a prolonged survival in several cancer forms. Here, we examined the clinicopat